Additionally, the present study showed that the 5-year survival rate of patients with the high mRNA expression of ARL9 was significantly lower than that of patients with low expression levels, and the high mRNA expression of ARL9 was an independent risk factor for a poor prognosis in patients with colon adenocarcinoma, as verified by the Cox regression analysis. Here, ARL9 is linked to colon adenocarcinoma.